Information Journal Paper
APA:
Copy. (2018). Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: A German phase IV study (TOLERATE). THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 11(-), 0-0. SID. https://sid.ir/paper/757164/en
Vancouver:
Copy. Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: A German phase IV study (TOLERATE). THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS[Internet]. 2018;11(-):0-0. Available from: https://sid.ir/paper/757164/en
IEEE:
Copy, “Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: A German phase IV study (TOLERATE),” THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, vol. 11, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/757164/en